Sort   by:  
 Page size 
GenomicsMED12L Gene Alterations Define Aggressive BRCA2-Mutant Prostate Cancers
Germline mutation of BRCA2 increases the lifetime risk of developing prostate cancer (PCa) by over 700%. BRCA2-mutant PCa have poorer prognosis than sporadic PCa, with rapid development of metastatic, castrate-resistant prostate cancer (mCRPC) and 5-year cancer-specific survival rates of ~50-60%1-4....
EGAS00001001615 | EGA
GenomicsBRCA_SNV_SR - samples
single nucleotide variant calls from somatic sniper, vcf format. input for subclonal reconstruction
EGAD00001003753 | EGA
GenomicsCPCG BRCA2 - samples
Aligned sequence data from 14 Prostate cancer samples with BRCA2 mutations
EGAD00001002739 | EGA
GenomicsBRCA_SNV - samples
single nucleotide variant calls from somatic sniper, vcf format
EGAD00001003752 | EGA
GenomicsBRCA_SV - samples
structural variant calls from Delly, vcf format
EGAD00001003754 | EGA
GenomicsCPCG-BRCA-ARRAY
Raw Array data from the CPCGene BRCA study
EGAD00010001196 | EGA
Sort   by:  
 Page size